The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study

R Klein, B E Klein, S E Moss, S M Meuer, R Klein, B E Klein, S E Moss, S M Meuer

Abstract

Purpose: To describe the prevalence and the 5-year incidence of retinal central and branch vein occlusion and associated risk factors.

Methods: The Beaver Dam Eye Study (n = 4,926) is a population-based study in which retinal vein occlusions were detected at baseline (1988-1990) and at a 5-year follow-up examination (1993-1995) by grading of 30 degrees color fundus photographs.

Results: The prevalence and 5-year incidence of retinal branch vein occlusion were each 0.6%. The prevalence of retinal central vein occlusion was 0.1%, and the 5-year incidence was 0.2%. While adjusting for age, the prevalence of branch vein occlusion was associated with hypertension (odds ratio [OR] 5.42, 95% confidence interval [CI] 2.18, 13.47), diabetes mellitus (OR 2.43, 95% CI 1.04, 5.70), pulse pressure (OR 1.24 for 10 mm Hg, 95% CI 1.03, 1.48), ocular perfusion pressure (OR 2.09 for 10 mm Hg, 95% CI 1.45, 3.01), arteriovenous nicking (OR 16.75, 95% CI 7.33, 38.24), and focal arteriolar narrowing (OR 22.86, 95% CI 8.43, 62.03). The age-adjusted incidence of retinal branch vein occlusion was associated with current smoking (OR 4.43 95%, CI 1.53, 12.84) compared with nonsmokers and to focal arteriolar narrowing (OR 5.24, 95% CI 1.97, 13.94) at baseline. While controlling for age, the incidence of branch vein occlusion was not associated with serum lipid levels, body mass index, white blood cell count, alcohol consumption, aspirin use, glaucoma, intraocular pressure, or ocular hypertension.

Conclusions: Retinal vein occlusion is infrequent in the population. These data suggest a strong association between retinal branch vein occlusion and retinal arteriolar changes. Data from larger populations are needed to further assess associations between risk factors and the incidence of retinal vein occlusions.

References

    1. Ophthalmology. 1992 Apr;99(4):509-14
    1. Eye (Lond). 1992;6 ( Pt 1):66-8
    1. Arch Ophthalmol. 1989 Jul;107(7):998-1000
    1. Ophthalmology. 1994 Jan;101(1):77-83
    1. Ophthalmology. 1991 Aug;98(8):1310-5
    1. Arch Ophthalmol. 1996 Oct;114(10):1243-7
    1. Trans Ophthalmol Soc U K. 1964;84:559-95
    1. Br J Ophthalmol. 1982 Mar;66(3):161-4
    1. Ophthalmology. 1993 Mar;100(3):423-8
    1. Ophthalmology. 1992 Jan;99(1):58-62
    1. Surv Ophthalmol. 1980 May-Jun;24(Suppl):335-610
    1. Ophthalmology. 1996 Aug;103(8):1169-78
    1. Ophthalmology. 1991 Jul;98(7):1128-34
    1. Ophthalmology. 1998 May;105(5):765-71
    1. Ophthalmologica. 1988;197(2):69-74
    1. Invest Ophthalmol Vis Sci. 1995 Jan;36(1):182-91
    1. Am J Ophthalmol. 1994 Feb 15;117(2):211-3
    1. Br J Ophthalmol. 1997 Aug;81(8):698-704
    1. Ophthalmology. 1996 Apr;103(4):551-60
    1. Br J Ophthalmol. 1977 Dec;61(12):741-53
    1. Clin Chem. 1977 May;23(5):882-4
    1. Br Med J. 1964 Oct 31;2(5417):1093-8
    1. Trans Ophthalmol Soc U K. 1969;88:191-210
    1. Arch Ophthalmol. 1982 Jul;100(7):1132-40
    1. Arch Environ Health. 1973 Mar;26(3):137-43
    1. Ophthalmology. 1990 Nov;97(11):1428-33
    1. Br Med J (Clin Res Ed). 1987 Dec 5;295(6611):1434-5
    1. Clin Chem. 1982 Oct;28(10):2088-94
    1. Arch Ophthalmol. 1985 Dec;103(12):1831-2
    1. Arch Intern Med. 1978 Feb;138(2):216-20
    1. Graefes Arch Clin Exp Ophthalmol. 1986;224(1):83-5
    1. Ophthalmologica. 1992;204(4):199-203
    1. Am J Ophthalmol. 1992 Jun 15;113(6):664-8
    1. Am J Ophthalmol. 1994 Apr 15;117(4):429-41
    1. Ophthalmology. 1990 Nov;97(11):1543-8
    1. Ophthalmology. 1992 Oct;99(10):1499-504
    1. Clin Chem. 1974 Apr;20(4):470-5

Source: PubMed

3
購読する